Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.

Published long after NCT00004992 ended. The report of the trial’s main result is not on the map, and the numbers here are shown and do not vote.

What the trial testedas reported · 3,234 people · 2022

Range includes no effect

Doesn’t vote: a later paper about the trial

+3%−22% to +37%

Smaller than almost all for cardiovascular events

As reported

HR 1.03, 95% CI 0.78–1.37

the abstract, start to end

… metformin versus placebo hazard ratio 1.03 (95% CI, 0.78-1.37; …

← favours treatmentfavours comparator →

could be chance

Cardiovascular events

HR 1.030.78–1.37

MetforminDiet, exercise & lifestyleCardiovascular events

1 / 3

2022

2023

2024

2025

2026

this paperpooled ittrialcites it